HAVCR2 and acute myeloid leukemia: TIM-3 expression on immune cells has been reported to be associated with disease activity and prognosis in multiple types of cancers, e.g. AML (13), pediatric B-precursor acute lymphoid leukemia (14), lung cancer (2, 4).